ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BRAF | B-Raf proto-oncogene, serine/threonine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CBL | Cbl proto-oncogene, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Mixed |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CSF3R | Colony stimulating factor 3 receptor (granulocyte) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CUX1 | Cut-like homeobox 1 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
DNM2 | Dynamin 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FAM46C | Family with sequence similarity 46, member C | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GOPC | Golgi-associated PDZ and coiled-coil motif containing | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
IL6ST | Interleukin 6 signal transducer | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
KIAA1549 | KIAA1549 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NF1 | Neurofibromin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
NF2 | Neurofibromin 2 (merlin) | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
NOTCH1 | Notch 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
PBRM1 | Polybromo 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PDGFRA | Platelet-derived growth factor receptor, alpha polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
SOCS1 | Suppressor of cytokine signaling 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
STAT3 | Signal transducer and activator of transcription 3 (acute-phase response factor) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
STAT5B | Signal transducer and activator of transcription 5B | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |